Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy in Heart Transplantation: New Strategies and Preliminary Results in Endomyocardial Biopsies

Tacrolimus (TAC) is an immunosuppressant drug approved both in the US and in the EU, widely used for the prophylaxis of organ rejection after transplantation. This is a critical dose drug: low levels in whole blood can lead to low exposure and a high risk of acute rejection, whereas overexposure put...

Descripción completa

Detalles Bibliográficos
Autores principales: De Gregori, Simona, De Silvestri, Annalisa, Cattadori, Barbara, Rapagnani, Andrea, Albertini, Riccardo, Novello, Elisa, Concardi, Monica, Arbustini, Eloisa, Pellegrini, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229567/
https://www.ncbi.nlm.nih.gov/pubmed/35745819
http://dx.doi.org/10.3390/pharmaceutics14061247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229567/
https://www.ncbi.nlm.nih.gov/pubmed/35745819
http://dx.doi.org/10.3390/pharmaceutics14061247

Ejemplares similares